发明名称 Di-N-substituted piperazines and 1,4-di-substituted piperidines as muscarinic antagonists
摘要 The specification describes Di-N-substituted piperazine or 1,4-di-substituted piperidine compounds in accordance with above formula (I) (including all isomers, salts, esters, and solvates), Variables Q, n, R, R1, R2, R3, R4, R21, R27, R28, X, and Z are as defined in the specification itself. The muscarinic antagonists are useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed as are synergistic combinations with acetylcholinesterase inhibitors.
申请公布号 NZ333322(A) 申请公布日期 2000.06.23
申请号 NZ19970333322 申请日期 1997.06.26
申请人 SCHERING CORPORATION 发明人 KOZLOWSKI, JOSEPH A;LOWE, DEREK B;CHANG, WEI K;DUGAR, SUNDEEP
分类号 C07D295/08;A61K31/445;A61K31/495;A61K31/496;A61K31/505;A61K31/506;A61P25/28;A61P43/00;C07D211/58;C07D239/34;C07D241/04;C07D295/088;C07D295/096;C07D311/68;C07D317/58;C07D317/62;C07D405/14;(IPC1-7):C07D213/643;A61K31/44;A61K31/35;C07D405/12 主分类号 C07D295/08
代理机构 代理人
主权项
地址